Adam C. Vandervoort - 19 Mar 2025 Form 4 Insider Report for Teladoc Health, Inc. (TDOC)

Role
CHIEF LEGAL OFFICER, SECRETARY
Signature
/s/ Adam C. Vandervoort
Issuer symbol
TDOC
Transactions as of
19 Mar 2025
Transactions value $
-$92,757
Form type
4
Filing time
21 Mar 2025, 16:20:16 UTC
Previous filing
04 Mar 2025
Next filing
03 Jun 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TDOC Common Stock Options Exercise +21.4K +39.69% 75.3K 19 Mar 2025 Direct F1
transaction TDOC Common Stock Sale -$92.8K -11K -14.62% $8.42 64.3K 20 Mar 2025 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TDOC Restricted Stock Units Options Exercise $0 -21.4K -33.33% $0.00 42.8K 19 Mar 2025 Common Stock 21.4K Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
F2 Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards.
F3 One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025.